Neogenomics

Apr 25, 2022

NeoGenomics, Eli Lilly to Offer Molecular Testing to Non-Small Cell Lung Cancer Patients

Apr 1, 2022

360Dx Top 30 Falls Slightly in March

Mar 29, 2022

NeoGenomics Stock Plummets on Predicted Lower Q1 Expectations, Departure of CEO

Feb 23, 2022

NeoGenomics Q4 Revenue Remains Flat but Core Business Grows 7 Percent

Feb 17, 2022

New Data Further Validates Inivata's MRD Test as Company Prepares Commercial Launch
Premium

Jan 24, 2022

NeoGenomics Partners With Biomarker Collaborative to Provide Lung Cancer Resources

Jan 11, 2022

NeoGenomics Blood-Based Minimal Residual Disease Test Receives CE Mark

Dec 16, 2021

Cowen Initiates Coverage of NeoGenomics at Outperform

Nov 8, 2021

Genetron Health, NeoGenomics Partner on Oncology Drug Clinical Trials and Testing

Nov 4, 2021

NeoGenomics Preparing for Commercialization of Inivata MRD Test in 2022
Premium

Nov 4, 2021

NeoGenomics Q3 Revenues Drop 3 Percent

Oct 19, 2021

Princess Margaret Cancer Centre, Inivata Partner on Clinical Liquid Biopsy Studies

Aug 6, 2021

NeoGenomics Q2 Revenues Grow 40 Percent

Jun 18, 2021

In Brief This Week: Hologic, NeoGenomics, Natera, Saga Diagnostics, and More

May 7, 2021

NeoGenomics Expects Inivata Buy to Help it Penetrate MRD Monitoring Market
Premium

Apr 19, 2021

Amgen, NeoGenomics Partner to Expand Biomarker Testing Access in NSCLC

Mar 24, 2021

NeoGenomics Acquires Trapelo Health in $65M Deal

Mar 16, 2021

NeoGenomics, Elevation Oncology Partner on NRG1 Fusion Testing for Clinical Trial Enrollment

Feb 24, 2021

NeoGenomics Q4 Revenue Grows 18 Percent, CEO to Retire

Feb 4, 2021

In Brief This Week: Quidel, Ortho Clinical Diagnostics, Hologic, Guardant Health, and More